Understanding Stage 2 Kidney Cancer (Renal Cell Carcinoma)

A diagnosis of kidney cancer, also known as renal cancer, requires strong partnership with your oncologist. This overview is designed to provide you with fundamental knowledge about Stage 2 disease, the standard treatment approaches and what you can expect, helping you prepare for informed discussions with your healthcare team.

What Does Kidney Cancer Mean?

Kidney cancer is a disease in which malignant (cancer) cells form in the tissues of the kidney. The vast majority of kidney cancers are a type called Renal Cell Carcinoma (RCC).

Stage 2 Definition: The staging system used for kidney cancer is the TNM system. For Stage 2, this means the tumor is relatively large (specifically, it measures more than 7 centimeters across) but critically, it is still contained entirely within the kidney and has not spread to lymph nodes or distant organs. This localized nature is what makes it treatable.

Various Kinds of RCC: While the treatment approach for Stage 2 is generally similar across types, understanding the specific subtype is important:

• Clear Cell RCC (ccRCC): This is the most common type, accounting for about 70-80% of cases.
• Papillary RCC: This is the second most common type.
• Chromophobe RCC: This type is less common and often has a better prognosis than the clear cell subtype.

“I think the first thing any patient can do to advocate for themselves is to question things and to get as educated as they can. ... You get thrown into the deep end with a cancer diagnosis,” Bryan Lewis, CEO and co-founder of KidneyCAN, said when asked about patient advocacy in an interview with CURE. “You have to, sometimes fight, sometimes push, and sometimes push back to question what's going on because they are treating you, and you are the patient. You have immense rights to decide what's going to happen to your body.”

Diagnostic Tests: How is Stage 2 Kidney Cancer Identified?

The path to diagnosis involves several steps to confirm the presence of cancer, determine its size and stage, and assess your overall health.

Tests include:

1. Imaging Scans (CT, MRI, Ultrasound): These are crucial for finding the tumor, measuring its size precisely to confirm Stage 2 status, and checking for any spread to adjacent structures or distant sites.
2. Blood and Urine Tests: These check kidney function, liver function and general health parameters. Kidney cancer can sometimes cause abnormal blood counts (anemia) or elevated calcium levels.
3. Biopsy (Needle Aspiration): A small sample of the tumor is taken with a needle and examined under a microscope. While surgery is often the primary treatment, a biopsy may be performed to confirm the specific type (clear cell, papillary, etc.) before definitive treatment is planned, especially if ablation is being considered.

“Right now, smaller biopsies are preferred to avoid large surgeries, which is good for patients. But small biopsies give less tissue, which can make accurate diagnosis harder. It’s important for clinicians to consider obtaining larger specimens when needed and to use advanced technologies,”Dr. Shuanzeng “Sam” Wei, of Fox Chase Cancer Center, cautioned in an interview on the topic of kidney cancer testing.

Stage 2 Kidney Cancer Treatment: Surgery and Beyond

The primary goal of treating Stage 2 kidney cancer is the complete removal of the tumor, and for localized disease, this is typically achieved through surgery.

1. Primary Treatment (Surgery)

• Radical Nephrectomy: This involves removing the entire kidney along with the adrenal gland and surrounding fatty tissue. This is the most common approach for large Stage 2 tumors.
• Partial Nephrectomy (Kidney-Sparing Surgery): This procedure involves removing only the tumor and a small rim of healthy tissue, leaving the rest of the kidney intact. While generally preferred to preserve kidney function, it can be more challenging for larger Stage 2 tumors. Your surgeon will discuss if this is a viable option based on the tumor's size and location.

Both procedures can often be performed using minimally invasive techniques (laparoscopic or robotic surgery), which may lead to smaller incisions, less pain and a faster recovery compared to open surgery.

“Minimally invasive surgery has been the hallmark of how surgery has evolved, benefiting patients in terms of their recovery and overall quality of life,” Dr. Ravi Munver, of Hackensack University Medical Center in Hackensack, New Jersey, emphasized to CURE. “The introduction of laparoscopic, or keyhole, surgery has progressed to robotic keyhole surgery. Through very small incisions, we can insert instruments with a telescopic camera to look inside the abdomen where the kidney is located and focus on removing the tumors or the entire kidney itself.”

2. Non-Surgical Options (Ablation)

For patients who are not surgical candidates due to other health issues, tumor ablation may be an option:

• Radiofrequency Ablation (RFA) or Cryoablation: These procedures destroy the tumor by heating it (RFA) or freezing it (cryoablation). These are typically reserved for smaller tumors, but may be used for a Stage 2 tumor if surgery poses too great a risk.

3. Systemic Therapy (Medical Treatment)

Systemic treatments (medications that travel through the bloodstream) are generally not used before or after surgery for standard localized Stage 2 RCC. However, they may be considered if:

• The cancer has highly aggressive features.
• The patient is participating in a clinical trial.
• There is a high risk of recurrence.

These systemic therapies primarily include Targeted Therapies and Immunotherapy (often called Immuno-Oncology).

Coping with Side Effects of Kidney Cancer Treatment

It is crucial to be proactive in discussing and managing side effects with your care team, as supportive care is highly effective.

Post-Surgical Side Effects (Most Common)

• Pain: Managed with medication, this typically resolves quickly as you heal.
• Fatigue: Feeling tired is normal after any major surgery. It's important to listen to your body and balance rest with light activity.
• Reduced Kidney Function: If a portion or an entire kidney is removed, the remaining kidney usually compensates. Your function will be monitored with blood tests.

Systemic Therapy Side Effects (If Applicable)

If you require targeted therapy or immunotherapy, potential side effects can include:

• Flu-like Symptoms: Chills, fever and muscle aches (common with immunotherapy).
• Gastrointestinal Issues: Diarrhea, constipation or nausea.
• Skin Changes: Rashes, dryness or peeling.
• Hypertension (High Blood Pressure): A known side effect of some targeted therapies.

The Path Ahead: Partnering with Your Kidney Cancer Care Team

A Stage 2 diagnosis is serious, but it is important to remember that it represents a localized cancer that often has an excellent prognosis following successful treatment. This overview is your foundation for moving forward.

The most important step you can take now is to engage openly with your medical oncologist and urologic surgeon. Use this information to formulate specific questions about your treatment plan, such as:

• “Based on my tumor's size and location, is a radical or partial nephrectomy recommended, and why?”
• “Will my surgery be performed robotically, and what is the typical recovery time?”
• “What follow-up schedule (surveillance) will I be on post-surgery?”

By asking specific questions and clearly communicating any concerns or side effects, you ensure your care is perfectly tailored to your individual needs and circumstances.

Editor’s Note: This guide is designed to be a starting point. Your personal experience will be unique. By using this information as a foundation for your discussions, you can partner with your oncologist to make the best decisions for your health.

References

1. “How Patients With Kidney Cancer Can Advocate for Themselves in Care,” by Bryan Lewis. CURE; Sept. 3, 2025. https://www.curetoday.com/view/how-patients-with-kidney-cancer-can-advocate-for-themselves-in-care
2. “Molecular Testing Improves Accuracy in Kidney Cancer Diagnosis,” by Spencer Feldman. CURE, Sept. 22, 2025. https://www.curetoday.com/view/molecular-testing-improves-accuracy-in-kidney-cancer-diagnosis
3. “Understanding Recent Treatment Advancements in Kidney Cancer Care,” by Ryan Scott. CURE; Sept. 22, 2025. https://www.curetoday.com/view/understanding-recent-treatment-advancements-in-kidney-cancer-care

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.